Is a
Patent attributes
Patent Jurisdiction
Patent Number
Date of Patent
November 21, 2017
Patent Application Number
15383662
Date Filed
December 19, 2016
Patent Citations Received
Patent Primary Examiner
Patent abstract
The invention is directed to modified T cells, methods of making and using isolated, modified T cells, and methods of using these isolated, modified T cells to address diseases and disorders. In one embodiment, this invention broadly relates to TCR-deficient T cells, isolated populations thereof, and compositions comprising the same. In another embodiment of the invention, these TCR-deficient T cells are designed to express a functional non-TCR receptor. The invention also pertains to methods of making said TCR-deficient T cells, and methods of reducing or ameliorating, or preventing or treating, diseases and disorders using said TCR-deficient T cells, populations thereof, or compositions comprising the same.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
